S&P 500   4,050.83 (+0.57%)
DOW   32,859.03 (+0.43%)
QQQ   315.68 (+0.95%)
AAPL   162.36 (+0.99%)
MSFT   284.05 (+1.26%)
META   207.84 (+1.21%)
GOOGL   100.89 (-0.49%)
AMZN   102.00 (+1.75%)
TSLA   195.28 (+0.72%)
NVDA   273.83 (+1.48%)
NIO   10.46 (+6.41%)
BABA   103.38 (+3.46%)
AMD   97.88 (+1.86%)
T   19.08 (+0.42%)
F   12.29 (+1.99%)
MU   63.09 (-0.71%)
CGC   1.76 (-2.76%)
GE   94.05 (-0.01%)
DIS   98.10 (+1.27%)
AMC   4.97 (-0.60%)
PFE   40.38 (+0.32%)
PYPL   74.39 (+0.28%)
NFLX   338.43 (+1.93%)
S&P 500   4,050.83 (+0.57%)
DOW   32,859.03 (+0.43%)
QQQ   315.68 (+0.95%)
AAPL   162.36 (+0.99%)
MSFT   284.05 (+1.26%)
META   207.84 (+1.21%)
GOOGL   100.89 (-0.49%)
AMZN   102.00 (+1.75%)
TSLA   195.28 (+0.72%)
NVDA   273.83 (+1.48%)
NIO   10.46 (+6.41%)
BABA   103.38 (+3.46%)
AMD   97.88 (+1.86%)
T   19.08 (+0.42%)
F   12.29 (+1.99%)
MU   63.09 (-0.71%)
CGC   1.76 (-2.76%)
GE   94.05 (-0.01%)
DIS   98.10 (+1.27%)
AMC   4.97 (-0.60%)
PFE   40.38 (+0.32%)
PYPL   74.39 (+0.28%)
NFLX   338.43 (+1.93%)
S&P 500   4,050.83 (+0.57%)
DOW   32,859.03 (+0.43%)
QQQ   315.68 (+0.95%)
AAPL   162.36 (+0.99%)
MSFT   284.05 (+1.26%)
META   207.84 (+1.21%)
GOOGL   100.89 (-0.49%)
AMZN   102.00 (+1.75%)
TSLA   195.28 (+0.72%)
NVDA   273.83 (+1.48%)
NIO   10.46 (+6.41%)
BABA   103.38 (+3.46%)
AMD   97.88 (+1.86%)
T   19.08 (+0.42%)
F   12.29 (+1.99%)
MU   63.09 (-0.71%)
CGC   1.76 (-2.76%)
GE   94.05 (-0.01%)
DIS   98.10 (+1.27%)
AMC   4.97 (-0.60%)
PFE   40.38 (+0.32%)
PYPL   74.39 (+0.28%)
NFLX   338.43 (+1.93%)
S&P 500   4,050.83 (+0.57%)
DOW   32,859.03 (+0.43%)
QQQ   315.68 (+0.95%)
AAPL   162.36 (+0.99%)
MSFT   284.05 (+1.26%)
META   207.84 (+1.21%)
GOOGL   100.89 (-0.49%)
AMZN   102.00 (+1.75%)
TSLA   195.28 (+0.72%)
NVDA   273.83 (+1.48%)
NIO   10.46 (+6.41%)
BABA   103.38 (+3.46%)
AMD   97.88 (+1.86%)
T   19.08 (+0.42%)
F   12.29 (+1.99%)
MU   63.09 (-0.71%)
CGC   1.76 (-2.76%)
GE   94.05 (-0.01%)
DIS   98.10 (+1.27%)
AMC   4.97 (-0.60%)
PFE   40.38 (+0.32%)
PYPL   74.39 (+0.28%)
NFLX   338.43 (+1.93%)
OTCMKTS:RDSMY

Koninklijke DSM - RDSMY Stock Forecast, Price & News

$33.85
+1.08 (+3.30%)
(As of 11/11/2022)
Add
Compare
Today's Range
$33.11
▼
$33.90
50-Day Range
$33.85
▼
$33.85
52-Week Range
$26.59
▼
$56.92
Volume
56,500 shs
Average Volume
116,034 shs
Market Capitalization
$23.67 billion
P/E Ratio
N/A
Dividend Yield
1.09%
Price Target
$161.33

Koninklijke DSM MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.86 Rating Score
Upside/​Downside
380.4% Upside
$162.60 Price Target
Short Interest
N/A
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.52 out of 5 stars

See Top Rated MarketRank™ Stocks Here

RDSMY stock logo

About Koninklijke DSM (OTCMKTS:RDSMY) Stock

Koninklijke DSM N.V., a science-based company, engages in nutrition, health, and sustainable living businesses in the Netherlands, Switzerland, rest of Europe, North America, Latin America, China, rest of Asia, and internationally. It operates through Nutrition, Materials, and Innovation Center segments. The Nutrition segment offers animal nutrition and health products, including vitamins, premixes, carotenoids, enzymes, microbes, and eubiotics; human nutrition and health products comprising vitamins, nutritional lipids, minerals, carotenoids, nutraceuticals, digestive enzymes, probiotics, and prebiotics, as well as active pharmaceutical ingredients; premix, market-ready solutions, and personalized nutrition; human milk oligosaccharides; and skin and sun care, hair care, and aroma ingredients; omega-3 fatty acids; and specialty food enzymes, cultures, bio-preservation, texturizing hydrocolloids, sugar reduction, and savory taste solutions. The Materials segment provides specialty plastics used in components for the electrical and electronics, automotive, flexible food-packaging, and consumer goods industries; and Dyneema, a fiber solution for use in personal protection, workwear, sports apparel, outdoor equipment, ropes and slings, synthetic chains, and nets for the aquaculture, and renewable energy sectors. The Innovation Center segment offers biomedical materials, and medical device and material manufacturing technologies in the areas of cardiovascular, continence care, dental, diabetes management, gynecology, neurology, ophthalmology, orthopedic, peripheral vascular, plastic and reconstructive surgery, and wound management. It also commercializes yeast technology yeast for ethanol production. The company was founded in 1902 and is headquartered in Heerlen, the Netherlands.

Receive RDSMY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Koninklijke DSM and its competitors with MarketBeat's FREE daily newsletter.

RDSMY Stock News Headlines

March 24, 2023 | investing.com
UBS maintains Koninklijke DSM at Buy
March 22, 2023 | finance.yahoo.com
Koninklijke DSM N.V. (DSM.AS)
March 30, 2023 | WealthPop (Ad)
Adam Mesh: “This Strategy Saved My Trading Career”
Adam Mesh was $50,000 in the hole - and ready to quit trading for good… Until he discovered the secret to unlocking double-digit income. This strategy has averaged 64% average gains in the last three years. Adam is hosting a free session to show ordinary folks how to execute this incredible strategy. Click here to let Adam show you how it’s done. pixel
February 24, 2023 | finanznachrichten.de
Royal DSM: DSM and Firmenich Have Obtained Competition Clearance from the European Commission
February 19, 2023 | seekingalpha.com
Koninklijke DSM N.V. (KDSKF) Q4 2022 Earnings Call Transcript
January 13, 2023 | wsj.com
Koninklijke DSM N.V.
January 11, 2023 | finanznachrichten.de
Royal DSM: DSM - delivery of shares
January 7, 2023 | finance.yahoo.com
DSM - delivery of shares
March 30, 2023 | WealthPop (Ad)
Adam Mesh: “This Strategy Saved My Trading Career”
Adam Mesh was $50,000 in the hole - and ready to quit trading for good… Until he discovered the secret to unlocking double-digit income. This strategy has averaged 64% average gains in the last three years. Adam is hosting a free session to show ordinary folks how to execute this incredible strategy. Click here to let Adam show you how it’s done. pixel
December 25, 2022 | uk.investing.com
Koninklijke DSM NV (0NPP)
November 22, 2022 | finance.yahoo.com
PUBLICATION OF THE OFFERING CIRCULAR IN RELATION TO THE MERGER BETWEEN DSM AND FIRMENICH AND THE LISTING OF DSM-FIRMENICH ON EURONEXT AMSTERDAM
November 17, 2022 | finance.yahoo.com
Science Based Targets initiative validates DSM's ambition to reduce direct greenhouse gas emissions as 1.5°C aligned
November 7, 2022 | finance.yahoo.com
Estimating The Fair Value Of Koninklijke DSM N.V. (AMS:DSM)
November 1, 2022 | finance.yahoo.com
DSM provides nine months 2022 trading update
October 10, 2022 | finance.yahoo.com
15 Most Valuable Dutch Companies in the World
August 3, 2022 | investing.com
Koninklijke DSM Earnings, Revenue Miss in Q2
August 2, 2022 | seekingalpha.com
Koninklijke DSM N.V. (RDSMY) CEO Geraldine Matchett on Q2 2022 Results - Earnings Call Transcript
August 2, 2022 | finance.yahoo.com
DSM reports H1 2022 results
August 2, 2022 | finance.yahoo.com
DSM sets new climate targets to accelerate route to net-zero
June 28, 2022 | finance.yahoo.com
Update on public exchange offer process
June 19, 2022 | benzinga.com
Koninklijke DSM (OTC:RDSMY), Short Interest Report
June 19, 2022 | benzinga.com
Koninklijke DSM (OTC:RDSMY), Analyst Ratings, Price Targets, Predictions
May 31, 2022 | finance.yahoo.com
DSM announces sale of Engineering Materials business
May 31, 2022 | finance.yahoo.com
Royal DSM to merge with Firmenich
May 31, 2022 | finance.yahoo.com
DSM and Firmenich to merge, becoming the leading creation and innovation partner in nutrition, beauty and well-being
May 10, 2022 | seekingalpha.com
DSM NV: Staying Resilient Through The Downcycle
May 10, 2022 | finance.yahoo.com
DSM announces results of 2022 Annual General Meeting of Shareholders
See More Headlines
Receive RDSMY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Koninklijke DSM and its competitors with MarketBeat's FREE daily newsletter.

RDSMY Company Calendar

Last Earnings
11/03/2020
Today
3/30/2023
Fiscal Year End
12/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Chemicals & allied products
Sub-Industry
N/A
Sector
Basic Materials
Current Symbol
OTCMKTS:RDSMY
Previous Symbol
NASDAQ:RDSMY
CUSIP
N/A
CIK
877016
Web
www.dsm.com
Phone
(145) 578-8111
Fax
31-45-571-9753
Employees
21,358
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$162.60
High Stock Price Forecast
$188.00
Low Stock Price Forecast
$140.00
Forecasted Upside/Downside
+376.6%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.86
Research Coverage
6 Analysts

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
0.30
Current Ratio
2.51
Quick Ratio
1.72

Sales & Book Value

Annual Sales
$10.89 billion
Price / Sales
2.17
Cash Flow
$2.29 per share
Price / Cash Flow
14.80
Book Value
$11.78 per share
Price / Book
2.87

Miscellaneous

Outstanding Shares
699,144,000
Free Float
N/A
Market Cap
$23.67 billion
Optionable
Not Optionable
Beta
1.00

Key Executives

  • Mr. Dimitri de Vreeze (Age 55)
    Co-CEO, COO & Member of the Managing Board
    Comp: $2.03M
  • Ms. Geraldine Matchett (Age 50)
    Co-CEO, CFO, Member of the Managing Board & Acting EVP of People & Organization
    Comp: $1.98M
  • Mr. Dave Huizing
    VP of Investor Relations
  • Ms. Lieke de Jong-Tops
    Sr. Communications Mang.
  • Mr. Rob J. Atsma (Age 76)
    Head of Energie Beheer Nederland
  • Mr. Paul Gilgen (Age 77)
    Head of Manufacturing & Purchasing of DSM Nutritional Products
  • Mr. Manfred Eggersdorfer (Age 71)
    Sr. VP of Nutrition Science & Advocacy
  • Mr. Bruno Müller (Age 66)
    Head of Strategy & VITAL Project - Nutritional Products
  • Mr. Jan Wolters (Age 79)
    Head of Fine Chemicals
  • Mr. Luca Rosetto (Age 59)
    Sr. VP of Operations - Nutritional Products

Key Competitors

View All Competitors













RDSMY Stock - Frequently Asked Questions

Should I buy or sell Koninklijke DSM stock right now?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Koninklijke DSM in the last year. There are currently 6 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" RDSMY shares.
View RDSMY analyst ratings or view top-rated stocks.

What is Koninklijke DSM's stock price forecast for 2023?

6 brokers have issued 12-month target prices for Koninklijke DSM's stock. Their RDSMY share price forecasts range from $140.00 to $188.00. On average, they predict the company's stock price to reach $162.60 in the next twelve months. This suggests a possible upside of 380.4% from the stock's current price.
View analysts price targets for RDSMY or view top-rated stocks among Wall Street analysts.

How have RDSMY shares performed in 2023?

Koninklijke DSM's stock was trading at $33.85 at the beginning of the year. Since then, RDSMY shares have increased by 0.0% and is now trading at $33.85.
View the best growth stocks for 2023 here.

How were Koninklijke DSM's earnings last quarter?

Koninklijke DSM (OTCMKTS:RDSMY) released its earnings results on Tuesday, November, 3rd. The basic materials company reported $0.30 EPS for the quarter, missing the consensus estimate of $0.31 by $0.01. The basic materials company earned $2.29 billion during the quarter.
Read the conference call transcript.

How often does Koninklijke DSM pay dividends? What is the dividend yield for Koninklijke DSM?

Koninklijke DSM declared a dividend on Saturday, August 6th. Investors of record on Friday, August 12th will be given a dividend of $0.1906 per share on Friday, September 2nd. This represents a dividend yield of 1.52%. The ex-dividend date is Thursday, August 11th.
Read our dividend analysis for RDSMY.

Is Koninklijke DSM a good dividend stock?

Koninklijke DSM (OTCMKTS:RDSMY) pays an annual dividend of $0.37 per share and currently has a dividend yield of 1.09%.
Read our dividend analysis for RDSMY.

What is Koninklijke DSM's stock symbol?

Koninklijke DSM trades on the OTCMKTS under the ticker symbol "RDSMY."

How do I buy shares of Koninklijke DSM?

Shares of RDSMY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Koninklijke DSM's stock price today?

One share of RDSMY stock can currently be purchased for approximately $33.85.

How much money does Koninklijke DSM make?

Koninklijke DSM (OTCMKTS:RDSMY) has a market capitalization of $23.67 billion and generates $10.89 billion in revenue each year.

How many employees does Koninklijke DSM have?

The company employs 21,358 workers across the globe.

How can I contact Koninklijke DSM?

Koninklijke DSM's mailing address is Het Overloon 1, Heerlrn P7, 6411 TE. The official website for the company is www.dsm.com. The basic materials company can be reached via phone at (145) 578-8111 or via fax at 31-45-571-9753.

This page (OTCMKTS:RDSMY) was last updated on 3/30/2023 by MarketBeat.com Staff